Anupam Rasayan India Limited — Updates, 13-02-2025: Press Release

Anupam Rasayan India Limited reported a strong performance in Q3 FY25, exhibiting a total revenue of ₹3,866 million, marking a robust 30% year-on-year growth. For the nine months ending December 31, 2024, total revenue stood at ₹9,428 million, a decrease of 14% compared to the previous year. Despite the dip in nine-month figures, EBITDA improved, reaching ₹1,208 million for the quarter, a 48% increase YoY, with a 31% EBITDA margin. Profit After Tax for Q3 FY25 surged to ₹542 million, reflecting a significant 108% year-on-year rise.

The Managing Director noted that the Pharma and Polymer segments are crucial growth drivers, contributing to recent improvements and projecting a continued upward trend into FY26, with expectations of a 30-35% revenue increase. The Agrochemical segment also shows recovery signs, particularly in the European market. Investors should watch closely for ongoing demand momentum and growth opportunities as the company navigates the shifting market dynamics.